Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: Is it necessary?

Table 1 Baseline characteristics of the study population (mean ± SD) n (%)

Variables	All patients (n = 229)	Group A (n = 157)	Group B (n = 72)	P value
Age (yr)	65.0 ± 9.3	65.0 ± 9.8	63.0 ± 9.5	0.080
Gender (M/F)	171 (74.7)/ 58 (25.3)	119 (76.0)/ 38 (24.0)	52 (72.0)/20 (28.0)	0.330
Etiology of cirrhosis				0.200
Hepatitis C	148 (64.6)	106 (67.0)	42 (58.3)
Hepatitis B	37 (16.2)	21 (14.0)	16 (22.2)
Hepatitis B + C	15 (6.6)	7 (5.0)	8 (11.1)
Non-viral	29 (12.7)	23 (14.0)	6 (8.3)
Child-Pugh score				0.005
A	218 (95.2)	154 (98.0)	64 (89.0)
B	11 (4.8)	3 (2.0)	8 (11.0)
C	0
MELD score	8.8 ± 1.5	8.5 ± 1.2	9.3 ± 1.9	0.001
Platelet count (× 103)	139 ± 60	150 ± 60	115 ± 51	0.001
Esophageal varices	63 (28.0)	34 (22.0)	29 (40.3)	0.003

MELD: Model for end-stage liver disease.